BE.Amycon Biobank & Data Registry UZ Leuven
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversitaire Ziekenhuizen KU Leuven
About this trial
The goal of this study is to collect and store human body material (HBM) of patients with amyloidosis in a biobank "BE.Amycon biobank" for future research and to collect clinical data of patients with amyloidosis in a database "BE.Amycon data registry".
Eligibility criteria
Qualifiers
Provide consent and sign informed consent form
Age 18 years or older
Diagnosis of amyloidosis (suspected or confirmed, any subtypes)
For the prospective sample collection only: newly diagnosed (any subtype) or at relapse (AL amyloidosis)
Disqualifiers
Not willing to sign informed consent
Not able to sign informed consent
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Universitaire Ziekenhuizen KU Leuven
Lead sponsor
Flemish institute of biotechnology (VIB)
Collaborator
Source ClinicalTrials.gov